Sjögren Sendromunda Nörolojik Tutulum: Olgular Temelinde Gözden Geçirme

Sjögren sendromu (SS), gözyaşı ve tükürük bezlerini tutan kronik otoimmün vaskülitik bir hastalıktır. SS’de santral sinir sistemi %1.5-20, periferik sinir sistemi ise %10 oranında etkilenebilmektedir. Bu çalışmada santral sinir sisteminin farklı bölümlerinin etkilendiği SS tanılı beş kadın olgunun klinik -nöroradyolojik bulguları ile tedaviye yanıtları güncel literatür bilgileri eşliğinde sunulmuştur. Sjögren sendromu (SS), gözyaşı ve tükürük bezlerini tutan kronik otoimmün vaskülitik bir hastalıktır. SS’de santral sinir sistemi %1.5-20, periferik sinir sistemi ise %10 oranında etkilenebilmektedir. Bu çalışmada santral sinir sisteminin farklı bölümlerinin etkilendiği SS tanılı beş kadın olgunun klinik -nöroradyolojik bulguları ile tedaviye yanıtları güncel literatür bilgileri eşliğinde sunulmuştur.

Anahtar Kelimeler:

Sjögren, vaskülit, bağ dokusu, ağrı, gabapentin

Neurological Involvement in Sjögren's Syndrome: Literature Review Based on Cases

Sjögren's syndrome (SS) is a chronic autoimmune vasculitic disease involving the lacrimal and salivary glands. The central and peripheral nervous system can be affected by the ratio of 1.5-20% and 10%, in SS, respectively. In this study, clinical-neuroradiological findings and response to treantment of five female patients with SS who were affected by different parts of the central nervous system were presented in the context of current literature. Sjögren's syndrome (SS) is a chronic autoimmune vasculitic disease involving the lacrimal and salivary glands. The central and peripheral nervous system can be affected by the ratio of 1.5-20% and 10%, in SS, respectively. In this study, clinical-neuroradiological findings and response to treantment of five female patients with SS who were affected by different parts of the central nervous system were presented in the context of current literature.

Keywords:

Sjögren’s, vasculitis, connective tissue, pain, gabapentin,

PDF

___

1. Goules AV, Tzioufas AG, Moutsopoulos HM. Classification criteria of Sjögren’s syndrome. J Autoimmun 2014;48(49):42-5.
2. Leonde MC, Alluno A, Cafaro G et al. The clinical spectrum of primary Sjögren's syndrome:beyond exocrine glands. Rheumatismo 2017;69(3)93-100.
3. Le Goff M, Cornec D, Jousse-Joulin S et al. Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome. Arthritis Res Ther 2017;6;19(1):269.
4. Theander E, Jonsson R, Sjostrom B, Brokstad K, Olsson P, Henriksson G. Prediction of Sjogren’s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling. Arthritis Rheumatol 2015;67(9):2427–2436.
5. Guellec D, Cornec D, Jousse-Joulin S et al. Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review. Autoimmun Rev 2013;12(3):416-20.
6. Escudero D, Olive A, Latorre P, Coll J. Central neurological manifestations of primary Sjögren's syndrome. Br J Rheumatol 1992;31(11):787.
7. Lee KM, Han KY, Kwon OP. Medical management for intractable pain arising from primary sjögren syndrome involving both brain and spinal cord: a case report. Ann Rehabil Med 2014;38(4):568-74.
8. Birnbaum J. Facial Weakness, Otalgia, and Hemifacial Spasm: A Novel Neurological Syndrome in a Case-Series of 3 Patients With Rheumatic Disease. Medicine (Baltimore) 2015;94(40).
9. Nakano Y, Yamamoto M, Komatsu K, Yagita M, Fujita M. Hypertrophic Pachymeningitis in Sjögren's Syndrome. Intern Med 2017;1.9406-17.
10. Koçer B, Tezcan ME, Batur HZ et al. Cognition, depression, fatigue, and quality of life in primary Sjögren's syndrome: correlations. Brain Behav 2016:13;6(12)